Preimplantation Genetic Testing (PGT)

At RMA, we know that preimplantation genetic testing (PGT) can give hopeful parents peace of mind on a variety of genetic issues. When paired with In Vitro Fertilization (IVF), it helps your care team increase the chance for a healthy, successful pregnancy.

reproductive medicine research

What are the different types of PGT?

 

PGT-A

Preimplantation genetic testing for aneuploidy

PGT-A is offered to all IVF patients and looks for extra or missing chromosomes in an embryo. RMA uses the most advanced PGT-A platform available. Validated over several years and rigorous clinical trials, it can detect chromosome abnormalities with more precision than many other platforms. As 50-70% of miscarriages have been shown to be due to chromosome imbalances in an embryo, using PGT-A can substantially reduce these risks.

PGT-M

Preimplantation genetic testing for monogenic/single gene defects

PGT-M is a test available for any patient or couple at risk to have a child with a condition caused by a single gene. Examples include cystic fibrosis, hereditary cancer predispositions or neurofibromatosis. A unique test is developed for every family based on their genetic makeup. RMA works closely with the PGT-M lab to make sure the testing is set up as soon as possible and families have the most accurate results possible.

infertility nursing staff
genetic testing pgt-a

PGT-SR

Preimplantation genetic testing for structural chromosomal rearrangements

The last type, PGT-SR, is an option for couples where one partner has a chromosome rearrangement such as a translocation or inversion. This testing looks for any unbalanced forms of these rearrangements, reducing the chance for a miscarriage and the chance to have a child with a chromosome abnormality.

Embryo Biopsy

No matter what type of PGT is done, an embryo biopsy is needed. An embryo biopsy takes place about 5 or 6 days after fertilization of the egg. It involves gently removing about five cells from a part of the embryo that will go on to make the placenta. Embryo biopsy has been shown to be a safe procedure that does not harm the embryo or the baby that develops from it.

local fertility clinic
IUI patients baby

A Research Study

Women who have three chromosomally-normal embryos as a result of In Vitro Fertilization (IVF) have a 94.9% chance of achieving pregnancy, new research conducted by Reproductive Medicine Associates (RMA) and presented at the annual meeting of the American Society for Reproductive Medicine (ASRM) shows.

Frequently Asked Questions About Preimplantation Genetic Testing (PGT)

Frequently Asked Questions about Preimplantation Genetic Testing for Increasing Your Chances of Conception

Speak to a Fertility Specialist & Get Started

Submit the form for an appointment. For immediate new patient scheduling, call 866-762-3140.

Call to ScheduleRequest We Call You
Schedule Your First Visit866-762-3140

Existing patients with inquiries, please call your local office or send a message via the Artemis Patient Portal.